BiotechTube
Home/InSitu Biologics/Mark Ereth, MD
ME

Mark Ereth, MD

Chief Medical Officer

InSitu Biologics

Therapeutic Areas

Pain ManagementOncologyInfection

InSitu Biologics Pipeline

DrugIndicationPhase
INSB200™Peri-operative Pain ManagementPre-clinical
INSB400™Localized Cancer Drug DeliveryEarly Development

Leadership Team at InSitu Biologics

DH
Dan Halpern
CEO
BT
Bill Taylor
Chief Science Officer
RW
Robert Wilson, MD
Board Chair
View full InSitu Biologics profile